BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
197 results:

  • 1. Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis.
    Wu Z; Wang X; Wu H; Du S; Wang Z; Xie S; Zhang R; Chen G; Chen H
    Comput Biol Med; 2024 May; 173():108307. PubMed ID: 38547657
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
    Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.
    Kim HJ; Kim YH
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474231
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Study on the mechanism of S100A4-mediated cancer oncogenesis in uveal melanoma cells through the integration of bioinformatics and in vitro experiments.
    Chen H; Zhang W; Shi J; Tang Y; Chen X; Li J; Yao X
    Gene; 2024 Jun; 911():148333. PubMed ID: 38431233
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FOXM1 promote the growth and metastasis of uveal melanoma cells by regulating CDK2 expression.
    Bai X; Li S; Luo Y
    Int Ophthalmol; 2024 Feb; 44(1):55. PubMed ID: 38342795
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
    Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
    Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
    Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
    Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evaluation of Ki67, Bax, Bcl-2 and kit in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
    Aytemiz Danyer I; Gürel A
    Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. STING promotes invasion and migration of uveal melanoma through p38‑MAPK signaling.
    Zhou X; Meng F; Xu B; Ma R; Cheng Y; Wu J; Qian J
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099424
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
    Zhang J; Tian H; Mao L; Si L
    Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis.
    Olteanu EG; Bataneant M; Puiu M; Chirita-Emandi A
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002964
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
    Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
    Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinicopathological and prognostic features of subungual melanoma in situ].
    Hu J; Ren M; Cai X; Lyu JJ; Shen XX; Kong YY
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1006-1011. PubMed ID: 37805391
    [No Abstract]    [Full Text] [Related]  

  • 14. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment.
    Sergi MC; Filoni E; Triggiano G; Cazzato G; Internò V; Porta C; Tucci M
    Curr Oncol Rep; 2023 Nov; 25(11):1247-1258. PubMed ID: 37773078
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic Aspects of Conjunctival Melanoma: A Review.
    Chang E; Demirci H; Demirci FY
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epidemiology, staging and management of mucosal melanoma of the head and neck: a narrative review.
    Jeong YJ; Thompson JF; Ch'ng S
    Chin Clin Oncol; 2023 Jun; 12(3):28. PubMed ID: 37417292
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
    Sun X; Zhang J; Hu J; Han Q; Ge Z
    BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification.
    Lei P; Xue L; Wu Y; Zhong J
    Bioengineered; 2022; 13(7-12):15033-15044. PubMed ID: 37105900
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
    Nong L; Wang W; Liang L; Li D; Li X; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.